Clinical Trial Update: Nexplanon Removal: Subcutaneous vs. Topical Lidocaine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring removal of Nexplanon using subcutaneous versus topical lidocaine for contraception.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Nexplanon (etonogestrel implant)

Snippet

Sponsor: Augusta University | Conditions: Contraception | Phase 4 | Status: UNKNOWN